Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06).
暂无分享，去创建一个
R. Herrmann | R. Winterhalder | M. Borner | D. Betticher | P. Brauchli | R. Popescu | A. Roth | D. Dietrich | A. Kollár | P. Saletti | R. V. Von Moos | D. Koeberle | S. Schacher | P. Moosmann | V. Hess | S. Anchisi | R. Moos | D. Baertschi | K. Matter | M. Frueh | M. Kueng | R. von Moos | Daniela Baertschi | Sabina Schacher